Neoadjuvant treatment: the future of patients with breast cancer

ESMO Open. 2018 May 17;3(4):e000371. doi: 10.1136/esmoopen-2018-000371. eCollection 2018.

Authors

F Reyal^{1

2}, A S Hamy², Martine J Piccart³

Affiliations

¹ Residual Tumor and Response to Treatment Laboratory, RT2Lab, PSL Research University, INSERM, U932 Immunity and Cancer, Institut Curie, Paris, France.
² Breast and Gynecologic Cancer and Reconstructive Surgery Team, Institut Curie, Paris, France.
³ Institut Jules Bordet, Université Libre de Bruxelles, Bruxelles, Belgium.

No abstract available

Keywords: breast cancer.

Publication types

Editorial